These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7711407)

  • 1. Development of resistance by Enterobacter cloacae during therapy of pulmonary infections in intensive care patients.
    Füssle R; Biscoping J; Behr R; Sziegoleit A
    Clin Investig; 1994 Dec; 72(12):1015-9. PubMed ID: 7711407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
    Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Failure of new beta-lactam antibiotics in the treatment of severe Enterobacter cloacae infections].
    Perronne C; Régnier B; Legrand P; Buré A; Frottier J; Vildé JL; Vachon F
    Presse Med; 1986 Oct; 15(36):1813-8. PubMed ID: 2947158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of colistin and tobramycin resistance among
    Dautzenberg MJD; Bayjanov JR; Leverstein-van Hall MA; Muller AE; Gelinck LBS; Jansen CL; Leyten EMS; Ruys T; Scharringa J; van der Starre RE; Fluit AC; Bonten MJM
    Antimicrob Resist Infect Control; 2018; 7():67. PubMed ID: 29796252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):208-11. PubMed ID: 10072803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
    Muller A; Lopez-Lozano JM; Bertrand X; Talon D
    J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to a beta-lactam antibiotic appearing during therapy for enterobacter cloacae sepsis in a child.
    Muñoz M; Márquez C; Taguas-Casaño M; Soult JA; López-Castilla JD; Alvarez-Silván AM
    Med Pediatr Oncol; 2003 Jan; 40(1):62-3. PubMed ID: 12426691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
    Cai JC; Zhou HW; Chen GX; Zhang R
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins.
    Yoshino Y; Okugawa S; Kimura S; Makita E; Seo K; Koga I; Matsunaga N; Kitazawa T; Ota Y
    J Microbiol Immunol Infect; 2015 Apr; 48(2):226-8. PubMed ID: 23017689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
    Novak A; Goic-Barisic I; Andrasevic AT; Butic I; Radic M; Jelic M; Rubic Z; Tonkic M
    Microb Drug Resist; 2014 Oct; 20(5):399-403. PubMed ID: 24716493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
    Mimoz O; Jacolot A; Padoin C; Caillon J; Louchahi K; Tod M; Samii K; Petitjean O
    J Antimicrob Chemother; 1997 Mar; 39(3):363-9. PubMed ID: 9096186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of multidrug-resistant Enterobacter cloacae: nosocomial outbreak or change of microbial ecology?
    Honderlick P; Saheb F; Cahen P
    Pathol Biol (Paris); 1999 May; 47(5):437-9. PubMed ID: 10418014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy of imipenem-colistin combination therapy against multiple-drug-resistant Enterobacter cloacae: in vitro activity and a Galleria mellonella model.
    Yang H; Chen G; Hu L; Liu Y; Cheng J; Ye Y; Li J
    J Microbiol Immunol Infect; 2018 Feb; 51(1):70-75. PubMed ID: 26906264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
    Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
    Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit.
    Finnström O; Isaksson B; Haeggman S; Burman LG
    Acta Paediatr; 1998 Oct; 87(10):1070-4. PubMed ID: 9825975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection.
    Stearne LE; Goessens WH; Mouton JW; Gyssens IC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3605-11. PubMed ID: 17646416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
    Dai W; Sun S; Yang P; Huang S; Zhang X; Zhang L
    Infect Genet Evol; 2013 Mar; 14():1-7. PubMed ID: 23220359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
    Lee NY; Lee CC; Li CW; Li MC; Chen PL; Chang CM; Ko WC
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7558-63. PubMed ID: 26416853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
    Mimoz O; Jacolot A; Padoin C; Tod M; Samii K; Petitjean O
    J Antimicrob Chemother; 1998 Mar; 41(3):367-72. PubMed ID: 9578163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.